RESEARCH TRIANGLE PARK, N.C., March 4 /PRNewswire/ -- Max Neeman International, a leading Indian CRO, adds to its Data Management and EDC services offering an alternative on the systematic data acquisition and data storage in a secure database for processing. The company already designs and implements a Clinical Data Management System (CDMS) using SAS PheedIt, a web based system used for paper based as well as EDC trials, with positive results. AMEDON's focus is electronic data capture software for the EDC trials only. All the procedures for both systems are compliant to FDA 21 CFR Part 11 and industry guidelines.
The AMEDON electronic data capture tool has certain unique features like: easy data entry/data capture at the site end, serious adverse event reporting alerts and direct capture of laboratory inputs.
Main features of the products:
Max Neeman offers a complete Data Management & Biostatistical solution to the clinical research/pharmaceutical industry. The approach is to fulfill client requirements, deliver Data Management & Biostatistical solutions which are regulatory–compliant, secure and cost-effective. Max Neeman's Data Management team handles trials across 60 countries.
About AMEDON GmbH
AMEDON specializes in developing, producing, and marketing web-based solutions for data acquisition, data presentation, and data analysis in clinical research and medical applications.
About Max Neeman International
Max Neeman International is one of the leading and largest CROs in India. We offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2000 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 22 cities with 5 regional offices. Please contact Donald Swankie, Vice President for more information (firstname.lastname@example.org +1.919.424.3345). http://www.neeman-medical.com
SOURCE Max Neeman InternationalBack to top
|SOURCE Max Neeman International|
Copyright©2010 PR Newswire.
All rights reserved